Dharmaj Crop Guard Ltd
Dharmaj Crop Guard Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #2 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
The short version
The company expects overall volume growth of 30% to 35% in H1 FY '26, with formulations growing around 28% to 35% and technicals about 28% to 30%. Revenue Growth: Management expects overall revenue growth of 20% to 25% for FY '26 and beyond, supported by volume growth of 30% to 35% in formulations and 28% to 30% in technicals for H1 FY '26.
From Dharmaj Crop Guard Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company expects overall volume growth of 30% to 35% in H1 FY '26, with formulations growing around 28% to 35% and technicals about 28% to 30%.
- Management targets a consolidated revenue growth of 20% to 25% for FY'26 and beyond.
- B2C domestic formulation revenue is projected to grow to INR 220-230 crores for FY'26, a 20-25% increase over last year.
- B2B bulk and formulation is targeted at INR 630-650 crores, and export revenue at INR 70-80 crores for FY'26.
- The technical segment's revenue is expected at INR 250-270 crores for FY'26, with a 20-25% growth outlook for FY'27.
2 more points from Dharmaj Crop Guard Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Dharmaj Crop Guard Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Tentative CAPEX for technicals is estimated at Rs. 75 to Rs. 100 crores.
- Planning a technical plant for herbicides in the future (next 1-2 years), currently focused on insecticides and fungicides at Saykha plant.
- Considering expansion for herbicides if opportunities materialize; no final decision yet.
- Current capacity utilization of the Saykha technical plant is around 65%, expected to increase to 70%+ in FY27. Additional capacity likely needed beyond 80% utilization, possibly by FY27-28.
- Export registrations for technical products ongoing in regulated countries (Brazil, Poland, US), expected to complete within 1-2 years, enabling business expansion.
2 more points from Dharmaj Crop Guard Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Dharmaj Crop Guard Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Registration processes for various products and countries are ongoing, with new licenses being obtained monthly, which implies an expanding order pipeline.
- Export business has grown significantly (50% year-on-year in H1 FY26), with further growth expected due to recent registrations in key markets like Brazil, the US, and Europe.
- The company is optimistic about the Rabi season and expects 20-25% growth in H2 FY26, indicating strong demand and order inflow.
2 more points from Dharmaj Crop Guard Ltd's call on order book
Create a free account to keep reading this call
Dharmaj Crop Guard Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹234 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dharmaj Crop Guard Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
- Khaitan Chemicals & Fertilizers Ltd (Q2 FY26)
Q2-FY26 Operational Revenue: INR 3,086 million, up 33.8% year-on-year (Q2-FY25: INR 2,306 million). Key investor presentation takeaways from Khaitan Chemical's
- Rama Phosphates Ltd (Q2 FY26)
Revenue from Operations for Q2 FY26: ₹24,566 Lacs . Key investor presentation takeaways from Rama Phosphates's Q2 FY26 investor presentation — and how it ranks
- Krishana Phosch. (Q2 FY26)
Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- 2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Dharmaj Crop Guard Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Dharmaj Crop Guard Ltd Q2 FY26 results?
The company expects overall volume growth of 30% to 35% in H1 FY '26, with formulations growing around 28% to 35% and technicals about 28% to 30%. Revenue Growth: Management expects overall revenue growth of 20% to 25% for FY '26 and beyond, supported by volume growth of 30% to 35% in formulations and 28% to 30% in technicals for H1 FY '26.
What is Dharmaj Crop Guard Ltd share price analysis?
Dharmaj Crop Guard Ltd currently shows a neutral. The stock trades at a P/E of 16.7 with a market cap of ₹915 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dharmaj Crop Guard Ltd planning capital expenditure?
Tentative CAPEX for technicals is estimated at Rs.
Keep Dharmaj Crop Guard Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
